- ホーム
- > 電子洋書
Description
Alzheimer’s disease is the most prevalent form of dementia. Although it was discovered about a century ago, the first drugs applied in treatment were only introduced in therapy in the last 30 years.
This book focuses on the clinical pharmacology of drugs that aim to delay the progression of Alzheimer’s disease, such as anticholinesterases and glutamate receptor antagonists, as well as treatment for the behavioral changes caused by the progression of the disease: antidepressants, antipsychotics, anxiolytics, and mood stabilizers.
Written by experts with solid professional experience, this book will appeal to pharmacologists, geriatricians, neurologists, psychiatrists, biomedical clinicians, and other healthcare professionals.
Table of Contents
1. Introduction.- 2. Principles of Pharmacology in Dementia.- 3. The Viability of Treatment Conditioned to the Pathophysiology of Alzheimer's Disease.- 4. The Use of Esterase Inhibitors.- 5. Pharmacology of NMDA (N-methyl-D-aspartate) receptor antagonists in Alzheimer’s Disease.- 6. Supportive Pharmacological Treatment.- 7. Herbal Medicines and Supplements.- 8. Emergency Situations.- 9. Relationships between Treatment and Clinical Evaluations.- 10. New Perspectives for Treatment in Alzheimer's Disease.
